01 10Xalkori
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 530
2018 Revenue in Millions : 524
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 544
2019 Revenue in Millions : 530
Growth (%) : 3
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 493
2020 Revenue in Millions : 544
Growth (%) : -9
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 465
2021 Revenue in Millions : 493
Growth (%) : -6
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 374
2022 Revenue in Millions : 465
Growth (%) : -20
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 55.00%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 438
2014 Revenue in Millions : 488
Growth (%) : 11%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 561
2015 Revenue in Millions : 488
Growth (%) : 15
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 594
2016 Revenue in Millions : 560
Growth (%) : 6
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 524
2017 Revenue in Millions : 594
Growth (%) : -12%
LOOKING FOR A SUPPLIER?